CRDL
Cardiol Therapeutics
CRDL
CRDL
43 hedge funds and large institutions have $9.6M invested in Cardiol Therapeutics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.07% more ownership
Funds ownership: 7.12% → 9.18% (+2.1%)
3% less capital invested
Capital invested by funds: $9.85M → $9.6M (-$253K)
Holders
43
Holding in Top 10
–
Calls
$188K
Puts
$5K
Top Buyers
| 1 | +$1.72M | |
| 2 | +$624K | |
| 3 | +$398K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$346K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$297K |
Top Sellers
| 1 | -$369K | |
| 2 | -$321K | |
| 3 | -$109K | |
| 4 |
Two Sigma Investments
New York
|
-$48.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$33.5K |